Author

Shin’ichiro Yasunaga

Observed names: S Yasunaga, S. Yasunaga, SHIN'ICHIRO YASUNAGA, SHIN’ICHIRO YASUNAGA, Shin'ichiro Yasunaga, Shinichiro Yasunaga, YASUNAGA, Shin'ichiro, Yasunaga Shin'ichiro, Yasunaga, Shin'ichiro, Yasunaga, Shin’ichiro, 安永晋一郎, 安永, 晋一郎, 安永晋一郎, 晋一郎安永

Institution: Fukuoka University

Observed institutions: Hiroshima University, Tokyo Medical and Dental University, Centre National de la Recherche Scientifique, Kyushu University, Institut Pasteur, Saga University, Iwate Medical University, Kyoto University, Fukuoka University, Saga Medical School Hospital, Kure Medical Center, Medical Institute of Bioregulation, Kyushu University, Fukuoka University Nishijin Hospital, Research Institute for Radiation Biology and Medicine, Hiroshima University

ORCID: 0000-0001-7163-7891

Observed ORCID: 0000-0001-7163-7891

OpenAlex ID: A5048864428

A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness

1999 · Shin'ichiro Yasunaga, M'hamed Grati, et al. · Nature Genetics · 597

OTOF Encodes Multiple Long and Short Isoforms: Genetic Evidence That the Long Ones Underlie Recessive Deafness DFNB9

2000 · Shin'ichiro Yasunaga, M'hamed Grati, et al. · The American Journal of Human Genetics · 210

Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis

2005 · Keichiro Mihara, Moniruddin Chowdhury, et al. · Blood · 130

Extensive HLA class II studies in 58 non‐DRB1*15 (DR2) narcoleptic patients with cataplexy

1997 · E. Mignot, A. Kimura, et al. · Tissue Antigens · 112

Different contribution of HLA‐DR and ‐DQ genes in susceptibility and resistance to Insulin‐dependent diabetes mellitus (IDDM)

1996 · S. Yasunaga, A. Kimura, et al. · Tissue Antigens · 111

DNA typing of HLA class II genes (HLA‐DR, ‐DQ and ‐DP) in Japanese patients with histiocytic necrotizing lymphadenitis (Kikuchi’s disease)

1999 · T. Tanaka, M. Ohmori, et al. · Tissue Antigens · 101

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome

2017 · Daichi Urushiyama, Wataru Suda, et al. · Scientific Reports · 97

Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia

2007 · M Chowdhury, K Mihara, et al. · Leukemia · 97

Dominant-negative STAT1 SH2 domain mutations in unrelated patients with mendelian susceptibility to mycobacterial disease

2012 · Miyuki Tsumura, Satoshi Okada, et al. · Human Mutation · 84

IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies

2002 · K. Izuhara, K. Arima, et al. · Current Drug Targets - Inflammation & Allergy · 79

Simple diagnosis ofSTAT1gain-of-function alleles in patients with chronic mucocutaneous candidiasis

2013 · Yoko Mizoguchi, Miyuki Tsumura, et al. · Journal of Leukocyte Biology · 75

Polycomb-group complex 1 acts as an E3 ubiquitin ligase for Geminin to sustain hematopoietic stem cell activity

2008 · Motoaki Ohtsubo, Shin'ichiro Yasunaga, et al. · Proceedings of the National Academy of Sciences · 68

Poly-ADP Ribosylation of Miki by tankyrase-1 Promotes Centrosome Maturation

2012 · Yuko Ozaki, Hirotaka Matsui, et al. · Molecular Cell · 65

Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene

2008 · N Ishikawa, S Okada, et al. · Journal of Medical Genetics · 57

Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells

2005 · Go Tanaka, Sachiko Kanaji, et al. · International Immunology · 53

Synergistic and persistent effect of T‐cell immunotherapy with anti‐CD19 or anti‐CD38 chimeric receptor in conjunction with rituximab on B‐cell non‐Hodgkin lymphoma

2010 · Keichiro Mihara, Kazuyoshi Yanagihara, et al. · British Journal of Haematology · 52

BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia

2008 · Joyeeta Bhattacharyya, Keichiro Mihara, et al. · Annals of Hematology · 51

MicroRNA‐135a‐3p as a promising biomarker and nucleic acid therapeutic agent for ovarian cancer

2017 · Satoshi Fukagawa, Kohei Miyata, et al. · Cancer Science · 49

Molecular bases for inherited human complement component C6 deficiency in two unrelated individuals

1996 · H Nishizaka, T Horiuchi, et al. · The Journal of Immunology · 42

Extensive Polymorphism of a (CA)n Microsatellite Located in the HLA-DQA1/DQB1 Class II Region

1995 · Claudia Macaubas, Joachim Hallmayer, et al. · Human Immunology · 39

Analysis of tumor necrosis factor‐α promoter polymorphism in type 1 diabetes: HLA‐B and ‐DRB1 alleles are primarily associated with the disease in Japanese

2000 · K. Hamaguchi, A. Kimura, et al. · Tissue Antigens · 37

The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-γ receptor 1 and has a dominant-negative effect on interferon-γ signal transduction

2007 · Satoshi Okada, Nobutsune Ishikawa, et al. · Journal of Medical Genetics · 36

Overexpression of BMI‐1 correlates with drug resistance in B‐cell lymphoma cells through the stabilization of survivin expression

2011 · Joyeeta Bhattacharyya, Keichiro Mihara, et al. · Cancer Science · 32

Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential

2010 · Yoshinori Ohno, Shin'ichiro Yasunaga, et al. · Proceedings of the National Academy of Sciences · 30

Molecular pathogenesis of a novel mutation, G108D, in short-chain acyl-CoA dehydrogenase identified in subjects with short-chain acyl-CoA dehydrogenase deficiency

2010 · Kenichiro Shirao, Satoshi Okada, et al. · Human Genetics · 29

Works count: 122

Citation count: 2,819

H-index: 26

I10-index: 44